Register for IPO Updates
US IPO Stats
IPO Industry Breakdown
Largest Global IPOs
Largest US IPOs
IPO News Archive
New Ways to Invest in IPOs - IPO ETFs
Week ahead: As many as 4 IPOs set to price during the week of October 26
Analyst IPO Market Commentary
Just one new company is scheduled to price this week. Three small initial public offerings have delayed IPOs for two weeks or more, and again join the
In the past week, the VIX Volatility Index fell to a 2-month low and the S&P 500 reached a 2-month high - roughly where each was before the market took a nosedive in August. Yet poor returns are haunting the IPO market: Just 37% of IPOs from 2015 trade above their offer price. IPO performance has not been lifted with the broader equity markets due to a decline in the health care (mostly biotech) and energy sectors. Since Labor Day, 76% of IPOs have priced below the range. 13 health care companies have gone public during this time, and 77% now trade below the offer price. Of the eight non-health care IPOs, only one is below its offer price.
Recent LBOs like
; +2%) and
; +17%) suggest that IPO investors could be receptive to the large, high-debt IPOs in the backlog like
) if given a sufficient discount to peers. Biotechs have attempted to price despite the sharp sell-off, evidenced by this week's MyoKardia. The technology sector has been largely absent, but
) 13% gain and a number of recent tech filings, notably
), suggests a come back is in store. If the VIX stays low and the broader market continues to rise, 2015 could see a moderately strong showing of 30 more IPOs, bringing the total above 180.
The heart of the IPO market: Biotech MyoKardia looks to raise $75 million
) is set to raise $75 million in the upcoming week at a valuation of $425 million. Those numbers could come down based on recent biotech IPO activity. Backed by Third Rock Ventures, MyoKardia is in Phase 1 trials for the heart condition hypertrophic cardiomyopathy. Top shareholder Sanofi intends to invest $25 million on the IPO. The company has raised almost $100 million in private funding so far. Third Rock Ventures has brought three biotechs public this year, including CytomX (
; -19%) earlier this month, Global Blood Therapeutics (
; +129%) in August and Blueprint Medicines (
; +23%) in April.
Three companies wait for their IPO window
), which makes low-power flash memory chips for "Internet of Things" devices,
had originally been on the calendar for the week of October 12. Since then, it has added insider buying and lowered its proposed market cap by 53%. Profitable Chinese manufacturers
Sole Elite Group
) could also price their delayed IPOs this week.
Renaissance Capital's IPO Calendar - Week of October 26, 2015
South San Francisco, CA
$15 - $17
Cowen & Company
Clinical-stage biotech developing therapies for heritable cardiomyopathies.
Fabless provider of flash memory chips for Internet of Things devices.
Sole Elite Group
$10 - $12
Chinese athletic shoe sole manufacturer.
Network 1 Financial
Chinese producer of disposable plastic cutlery and other food service products.
IPO ETF manager Renaissance Capital
Find out why institutional investors rely on Renaissance Capital's
for these IPOs.
Follow us on Twitter (
) for IPO news as it happens and
register for our updates
on the IPO market.
IPO pipeline update: The most active October for filings with a full week remaining
Companies hoping to go public before Thanksgiving had to have filed already, but October's 30 filings - tied with 2013 as the most active October in 10 years - suggest an active fourth quarter ahead. High-growth craft brewer
) was the largest new filer, looking to raise $173 million. Energy MLPs have been a rare sight, but
Noble Midstream Partners LP
) joined the pipeline. In addition, three biotech IPOs filed;
) have set deal sizes of $86 million.
IPO Market Snapshot
152 IPOs have raised $28 billion in 2015, and the average IPO has a return of -5%. The Renaissance IPO Indices are market cap weighted baskets of newly public companies. The Renaissance IPO Index is down 7% year-to-date, compared to +1% for the S&P 500. Renaissance Capital's
(NYSE: IPO) tracks the index, and
top ETF holdings
include Alibaba (
), Twitter (
) and Hilton Worldwide (
). The Renaissance International IPO Index is down 1% year-to-date, in line with the ACWX. Renaissance Capital’s International
(NYSE: IPOS) tracks the index, and
top ETF Holdings
include Recruit Holdings and Samsung C+T.
To find out if this is the best ETF for you, visit our
IPO Investing page
Keywords / Tickers:
Recently Priced IPOs
ETF Express Award:
ETFExpress awards are based on a 'peer review system' whereby readers - including institutional and high net worth investors as well as managers and other industry professionals at fund administrators, brokers, custodians and advisers - are invited to elect a 'best in class' in a series of categories via an online survey. In each category, the firms with the most votes at the end of the voting period are subject to a final review by ETFExpress's Senior Editorial team.
Past performance does not guarantee future results. The performance data quoted represents past performance and current returns may be lower or higher. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than the original cost. Investors should consider the investment objectives, risks, charges and expenses carefully before investing.
As stated in the Prospectus, the total annual operating expenses for the Fund was 3.48%. The Adviser has contractually agreed to keep net expenses from exceeding 2.50% of the Fund's average daily net assets for at least a year from the date of the Prospectus and for an indefinite period thereafter subject to annual re-approval of the agreement by the Board of Trustees.
An investor cannot invest directly in an index. Index returns do not represent Fund returns. The Index does not charge management fees or brokerage expenses, nor does the Index lend securities, and no revenues from securities lending were added to the performance shown.
Definitions: Net Asset Value (NAV) of the fund is calculated by dividing the total value of all the securities in its portfolio, less any liabilities, by the number of fund shares outstanding. Market Price is current value at which an asset or service can be bought or sold. Premium/Discount is provided to show the comparison of the daily net asset value (NAV) and the midpoint of the closing bid/ask for each of the funds.
Renaissance IPO Index® (IPOUSA)
is a stock market index based upon a portfolio of U.S.-listed newly public companies that includes securities prior to their inclusion in core U.S. equity portfolios.
Renaissance International IPO Index® (IPOXUS)
is a stock market index based upon a portfolio of newly public companies listed on non-U.S. exchanges.
The S&P 500® Index (SPX) is a stock market index which includes 500 U.S. listed companies and seeks to capture approximately 80% coverage of available U.S. market capitalization.
Risk Disclosure: Investments in the
Renaissance IPO ETF, symbol "IPO"
Renaissance International IPO ETF, symbol "IPOS"
(the "ETFs"), and the
Global IPO Fund, symbol "IPOSX"
(the "Mutual Fund") are subject to investment risk, including possible loss of the principal amounts invested. The ETFs and the Mutual Fund (the "Funds") invest in companies that have recently completed initial public offerings. These stocks are unseasoned equities lacking trading history, a track record of reporting to investors and widely available research coverage which many result in extreme price volatility. Due to a greater number of IPOs in certain segments, the Funds may also be subject to information technology and financial sector risk, small and mid-capitalization company risk, and, for the Renaissance International IPO ETF, emerging markets risk. The Funds may hold securities in the form of Depository Receipts, REITs, and Partnership Units which have greater risks than common shares. The strategies have high portfolio turnover and securities lending risks. The returns of the ETFs may not match the return of the respective indices. The ETFs are classified as non-diversified investment companies subject to concentration risk.
Prospectus: Investors should consider the investment objectives, risks, charges and expenses carefully before investing. For a prospectus and/or summary prospectus with this and other information, please visit
. Read the prospectus carefully before investing. Renaissance Capital Investments, Inc., distributor for the Mutual Fund. Foreside Fund Services, LLC, distributor for the ETFs, 1-866-486-6645.
Definitions: The Renaissance IPO Index® is a stock market index based upon a portfolio of U.S.-listed newly public companies that includes securities prior to their inclusion in core U.S. equity portfolios. The S&P 500® Index is a stock market index based on the market capitalizations of 500 large companies whose common stock is publicly traded on the NYSE or Nasdaq.
The information contained herein is proprietary and copyrighted. The media is welcome to use our information and ideas, provided that the following sourcing is included: Renaissance Capital - manager of IPO-focused ETFs.
The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital, the Renaissance IPO ETF (symbol: IPO), the Renaissance International IPO ETF (symbol: IPOS), or the Global IPO Fund (symbol: IPOSX), may have investments in securities of companies mentioned.
Register for Updates
Renaissance Capital LLC is an SEC-registered investment adviser.
Renaissance Capital Investments, Inc. is a
-registered broker-dealer, and member of
© 2016 Renaissance Capital LLC. All rights reserved.